These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 21455584)
21. An AKT activity threshold regulates androgen-dependent and androgen-independent PSA expression in prostate cancer cell lines. Paliouras M; Diamandis EP Biol Chem; 2008 Jun; 389(6):773-80. PubMed ID: 18627304 [TBL] [Abstract][Full Text] [Related]
22. YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia. Sun HL; Liu YN; Huang YT; Pan SL; Huang DY; Guh JH; Lee FY; Kuo SC; Teng CM Oncogene; 2007 Jun; 26(27):3941-51. PubMed ID: 17213816 [TBL] [Abstract][Full Text] [Related]
23. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1. Zaia A; Fraizer GC; Piantanelli L; Saunders GF Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720 [TBL] [Abstract][Full Text] [Related]
24. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro. Lyne JC; Melhem MF; Finley GG; Wen D; Liu N; Deng DH; Salup R Cancer J Sci Am; 1997; 3(1):21-30. PubMed ID: 9072304 [TBL] [Abstract][Full Text] [Related]
25. Ligand-independent activation of androgen receptors by Rho GTPase signaling in prostate cancer. Lyons LS; Rao S; Balkan W; Faysal J; Maiorino CA; Burnstein KL Mol Endocrinol; 2008 Mar; 22(3):597-608. PubMed ID: 18079321 [TBL] [Abstract][Full Text] [Related]
26. A novel nuclear role for the Vav3 nucleotide exchange factor in androgen receptor coactivation in prostate cancer. Rao S; Lyons LS; Fahrenholtz CD; Wu F; Farooq A; Balkan W; Burnstein KL Oncogene; 2012 Feb; 31(6):716-27. PubMed ID: 21765461 [TBL] [Abstract][Full Text] [Related]
27. Expression of group IIa secretory phospholipase A2 increases with prostate tumor grade. Graff JR; Konicek BW; Deddens JA; Chedid M; Hurst BM; Colligan B; Neubauer BL; Carter HW; Carter JH Clin Cancer Res; 2001 Dec; 7(12):3857-61. PubMed ID: 11751475 [TBL] [Abstract][Full Text] [Related]
28. Overexpression of secretory phospholipase A2-IIa supports cancer stem cell phenotype via HER/ERBB-elicited signaling in lung and prostate cancer cells. Lu S; Dong Z Int J Oncol; 2017 Jun; 50(6):2113-2122. PubMed ID: 28440478 [TBL] [Abstract][Full Text] [Related]
29. Group IIa secretory phospholipase A2 (sPLA2IIa) and progression in patients with lung cancer. Wang M; Hao FY; Wang JG; Xiao W Eur Rev Med Pharmacol Sci; 2014; 18(18):2648-54. PubMed ID: 25317799 [TBL] [Abstract][Full Text] [Related]
30. PC-1/PrLZ contributes to malignant progression in prostate cancer. Zhang H; Wang J; Pang B; Liang RX; Li S; Huang PT; Wang R; Chung LW; Zhau HE; Huang C; Zhou JG Cancer Res; 2007 Sep; 67(18):8906-13. PubMed ID: 17875733 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of interleukin-1beta-induced group IIA secretory phospholipase A2 expression by peroxisome proliferator-activated receptors (PPARs) in rat vascular smooth muscle cells: cooperation between PPARbeta and the proto-oncogene BCL-6. Ravaux L; Denoyelle C; Monne C; Limon I; Raymondjean M; El Hadri K Mol Cell Biol; 2007 Dec; 27(23):8374-87. PubMed ID: 17908795 [TBL] [Abstract][Full Text] [Related]
32. Secretory type II phospholipase A2 is produced and secreted by epicardial adipose tissue and overexpressed in patients with coronary artery disease. Dutour A; Achard V; Sell H; Naour N; Collart F; Gaborit B; Silaghi A; Eckel J; Alessi MC; Henegar C; Clément K J Clin Endocrinol Metab; 2010 Feb; 95(2):963-7. PubMed ID: 20008021 [TBL] [Abstract][Full Text] [Related]
33. Autocrine and paracrine transcriptional regulation of type IIA secretory phospholipase A2 gene in vascular smooth muscle cells. Jaulmes A; Janvier B; Andreani M; Raymondjean M Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1161-7. PubMed ID: 15802623 [TBL] [Abstract][Full Text] [Related]
34. Novel interaction between the co-chaperone Cdc37 and Rho GTPase exchange factor Vav3 promotes androgen receptor activity and prostate cancer growth. Wu F; Peacock SO; Rao S; Lemmon SK; Burnstein KL J Biol Chem; 2013 Feb; 288(8):5463-74. PubMed ID: 23281476 [TBL] [Abstract][Full Text] [Related]
35. Expression of Secretory Phospholipase A2 Group IIa in Breast Cancer and Correlation to Prognosis in a Cohort of Advanced Breast Cancer Patients. Jespersen SS; Stovgaard ES; Nielsen D; Christensen TD; Buhl ASK; Christensen IJ; Balslev E Appl Immunohistochem Mol Morphol; 2021 Jan; 29(1):e5-e9. PubMed ID: 32217848 [TBL] [Abstract][Full Text] [Related]
36. Secretory Phospholipase A2 IIa Mediates Expression of Growth Factor Receptors in Esophageal Adenocarcinoma. Halpern AL; Kohtz PD; White AM; Houk AK; Rehring JF; Hanson L; McCarter MD; Joshi M; Meng X; Fullerton DA; Weyant MJ Dig Dis Sci; 2021 Mar; 66(3):784-795. PubMed ID: 32277371 [TBL] [Abstract][Full Text] [Related]